Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody

Journal of the Royal Society of Medicine, Supplement

Volumn 102, Issue SUPPL.1, 2009, Pages

  Thomas, Matthew F ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AZITHROMYCIN; CEFTAZIDIME; CEFUROXIME; ITRACONAZOLE; METHYLPREDNISOLONE; OMALIZUMAB; OXYGEN; PREDNISOLONE; TOBRAMYCIN; VORICONAZOLE; ANTI-IGE; ANTIIDIOTYPIC ANTIBODY; ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN E ANTIBODY; MONOCLONAL ANTIBODY;

ADD ON THERAPY; BIRTH; BRONCHOPULMONARY ASPERGILLOMA; CASE REPORT; CHILD; COMMON COLD; CONFERENCE PAPER; COUGHING; CYSTIC FIBROSIS; DRUG DOSE INCREASE; DYSPNEA; GENOTYPE; HERPES ZOSTER; HOSPITAL ADMISSION; HUMAN; LIFE; MALE; MECONIUM ILEUS; PHYSIOTHERAPY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SPUTUM; THORAX RADIOGRAPHY; WHEEZING; ARTICLE; HYPERSENSITIVITY; LUNG ASPERGILLOSIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; CHILD; CYSTIC FIBROSIS; HUMANS; HYPERSENSITIVITY; MALE; METHYLPREDNISOLONE; TREATMENT OUTCOME;

EID: 68949176938     PISSN: 02675331     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.2009.s19011     Document Type: Conference Paper

References (15)

1. Mearns M, Young W, Baten J. Transient pulmonary infiltrations in cystic fibrosis due to allergic aspergillosis. Thorax 1965;20:385-392
2. Mastella G, Rainisio M, Harms HK, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J 2000;16:464-471
3. Stevens DA, Moss RB, Kurup VP, et al. Allergic bronchopulmonary aspergillosis - state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003;37(Suppl.):225-264
4. Cunningham S, Madge SL, Dinwiddie R. Survey of criteria used to diagnose allergic bronchopulmonary aspergillosis in cystic fibrosis. Arch Dis Child 2001;84:89 (Pubitemid 32060148)
5. Skowronski E, Fitzgerald D. Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis. Med J Aus 2005;182:482-484 (Pubitemid 40667818)
6. Brynes CA, Jaksic M, Tate JC. 21% prevalence of ABPA in a regional paediatric cystic fibrosis clinic - how high is too high?. J Cystic Fibrosis 2008;7:S58
7. Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2000;175:967
8. Skov M, Poulsen LK, Koch C. Increased antigen-specific Th-2 response in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Paediatr Pulmonol 1999;27:74-79 (Pubitemid 29104444)
9. Thomson JM,Wesley A, Brynes C, Nixon G. Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis. Paediatr Pulmonol 2006;41:164-170 (Pubitemid 43165446)
10. Cohen-Cymberknoh M, Blau H, Shoseyov D, Efrati O, Armoni S, Kerem E. Intravenous methylprednisolone for allergic bronchopulmonary aspergillosis in CF. J Cystic Fibrosis 2008;7:S58
11. Milgrom H, Flick RB, Su JQ, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;341:1966-1973 (Pubitemid 30010404)
12. Djukanovic R, Wilson SJ, Kraft M, et al. Effects of treatment with ant-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2005;171:88-89
13. Walker S, Monteil M, Phelan K, Lasserson TJ,Walters EH. Anti IgE for chronic asthma in adults and children. Cochrane Database Syst Rev 2006;2
14. van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody. Thorax 2007;62:276-277 (Pubitemid 46579813)
15. Zirbes JM, Milla CE. Steroid-sparing effect of Omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis. Paediatr Pulmonol 2008;43:607-610